Liensinine alleviates septic heart injury by targeting inflammation, oxidative stress, apoptosis, and autophagy.

Acta Biochim Biophys Sin (Shanghai) · 2023 · PMC10160220 · PMID 36951482

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

an increasing trendno p-value reported

According to our results, compared with the control group, the LC3 II/I value increased after LPS stimulation, and LC3 II/I also showed an increasing trend after liensinine administration.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.